menu
    • menu

    Company profile for Anaveon

    NEW Drugs in Dev: 2
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anaveon is committed to transforming immunological insights into life-saving therapies. With a vision to use our expertise in cutting-edge immunology to design and develop treatments that benefit patients and society, the team have the skills to make it happen and are ready to take Anaveon’s first drug into clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AnaveonSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Technologiepark Basel Hochbergerstrasse 60C 4057 Basel
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://anaveon.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anaveon-ag/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anaveon Reports ANV600 Clinical Trial Benefit at ASCO 2026
    Anaveon Reports ANV600 Clinical Trial Benefit at ASCO 2026

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302549/0/en/anaveon-reports-clinical-benefit-of-anv600-in-the-expand-1-phase-1-clinical-trial-at-asco-2026-and-actively-seeks-partners-for-its-legacy-oncology-portfolio.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Anaveon Appoints New CSO and CBO to Leadership Team
    Anaveon Appoints New CSO and CBO to Leadership Team

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297167/0/en/anaveon-strengthens-leadership-team-with-appointments-of-eric-zanelli-as-chief-scientific-officer-and-jill-jene-as-chief-business-officer.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    Anaveon Names Thomas P. Mathers Board Chair
    Anaveon Names Thomas P. Mathers Board Chair

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293688/0/en/anaveon-appoints-thomas-p-mathers-as-chair-of-the-board-of-directors.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Anaveon Shares ANV600 Data at ASCO, Seeks Oncology Partners
    Anaveon Shares ANV600 Data at ASCO, Seeks Oncology Partners

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3291580/0/en/anaveon-announces-presentation-of-positive-anv600-clinical-data-at-asco-2026-and-actively-seeks-partners-for-its-legacy-oncology-portfolio.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Anaveon Names Thaminda Ramanayake CEO
    Anaveon Names Thaminda Ramanayake CEO

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260161/0/en/Anaveon-appoints-Biotech-Leader-Thaminda-Ramanayake-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Anaveon appoints Dr. Richard Sachse as Chief Medical Officer
    Anaveon appoints Dr. Richard Sachse as Chief Medical Officer

    19 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-18/anaveon-appoints-dr-richard-sachse-as-chief-medical-officer

    PHARMAWEB
    19 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search